
Zebra Medical Vision
Zebra builds the next generation medical imaging research platform where computer vision and deep learning researchers can develop meaningful applications using best of breed computational power and large clinical data sets.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
$200m Valuation: $200m | Acquisition | ||
Total Funding | 000k |



















Related Content
Zebra Medical Vision was established in 2014 by Eyal Gura, Eyal Toledano, and Elad Benjamin, with the mission of applying artificial intelligence to medical imaging to enhance diagnostic speed and accuracy. The company's founding was inspired by Gura's personal experience following a diving accident in Mexico, where he was at a well-equipped scanning facility that lacked a radiologist to interpret the images. This highlighted the global gap between the demand for and supply of imaging diagnostics. Gura, a serial entrepreneur who has sold companies to eBay and Getty Images, partnered with Toledano, an MIT-trained developer, and Benjamin, a veteran healthcare IT executive. Gura has a background as a venture partner at Pitango and was recognized as a Young Global Leader by the World Economic Forum. Toledano served in an elite intelligence technology unit of the IDF, while Benjamin has held senior roles at companies like Lumenis and Carestream, with experience taking companies public.
Zebra Medical Vision operates in the AI medical imaging market, developing an analytics platform that assists healthcare institutions in identifying at-risk patients for improved preventative care. The company's business model is multifaceted, primarily revolving around a subscription-based Software as a Service (SaaS) platform for healthcare providers. Additionally, revenue is generated through licensing agreements with medical device manufacturers who embed Zebra's algorithms into their own products. A notable partnership includes the integration of their algorithms into Philips' IntelliSpace AI Workflow Suite. In a significant milestone, Zebra Medical Vision was acquired by Nanox in August 2021 in a deal valued at up to $200 million, becoming a wholly-owned subsidiary.
The company's core product is an AI-driven platform that analyzes medical images from CT scans, X-rays, and mammograms to automatically detect signs of various diseases and chronic conditions. The platform is designed to seamlessly integrate with existing hospital picture archiving and communication systems (PACS) and worklists, providing real-time alerts and insights to radiologists. This assists in prioritizing urgent cases, such as brain bleeds and pneumothorax, and detecting early signs of conditions like breast cancer, vertebral compression fractures, and high coronary calcium levels. Zebra Medical has secured numerous FDA clearances and CE marks for its algorithms across multiple imaging modalities, covering oncology, bone health, cardiovascular, and respiratory conditions. For instance, its HealthMammo tool triages suspicious mammograms, and another patented solution creates 3D bone models from standard X-rays for orthopedic surgery planning.
Keywords: medical imaging, artificial intelligence, radiology, diagnostic software, predictive analytics, FDA clearance, computed tomography, population health, deep learning, healthcare IT